COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,550 Articles (22,881 medRxiv, 8,669 bioRxiv)

Most recent first Previous |  Page 703: Articles 7021-7030  | Next

Metabolomic and gut microbiome profiles across the spectrum of community-based COVID and non-COVID disease: A COVID-19 Biobank study.
Österdahl, M. F., Whiston, R., Sudre, C. H., Asnicar, F., Cheetham, N. J., Blanco Miguez, A., Bowyer, V., Antonelli, M., Snell, O., dos Santos Canas, L., Hu, C., Wolf, J., Menni, C., Malim, M., Hart, D., Spector, T., Berry, S., Segata, N., Doores, K., Ourselin, S., Duncan, E. L., Steves, C. J.
10.1101/2022.08.07.22278510 — Posted: 2022-08-09
The prognostic value of transthoracic echocardiography findings in hospitalized adult patients with COVID-19: A single-center retrospective analysis
Muliawan, H. S., Agarwal, R., Nugraha, R. A., Priyonugroho, G., Hertine, S., Wicaksono, S. H., Almazini, P., Zamroni, D.
10.1101/2022.08.07.22278506 — Posted: 2022-08-09
Clinical effectiveness of SARS-CoV-2 booster vaccine against Omicron infection in residents and staff of Long-Term Care Facilities: a prospective cohort study (VIVALDI)
Stirrup, O., Shrotri, M., Adams, N. L., Krutikov, M., Nacer-Laidi, H., Azmi, B., Palmer, T., Fuller, C., Irwin-Singer, A., Baynton, V., Tut, G., Moss, P., Hayward, A., Copas, A., Shallcross, L.
10.1101/2022.08.08.22278532 — Posted: 2022-08-09
Utility of IL-6 in the diagnosis, treatment and prognosis of COVID-19 patients: A longitudinal study
Jain, V., Kumar, P., Panda, P. K., Kaushal, K., Mirza, A. A., S, V.
10.1101/2022.08.07.22278524 — Posted: 2022-08-09
NO2 pollution decrease in big cities of Latin America during COVID-19 pandemic
Poullain, M., Guerrieri, J. M., Miller, M., Utges, M. E., Santini, M. S., Manteca Acosta, M., Fernandez, A. D., Marsico, F. L.
10.1101/2022.08.08.22277819 — Posted: 2022-08-09
Effects of behavioral restrictions on COVID-19 spread
Sasaki, K., Ikeda, Y., Nakano, T.
10.1101/2022.08.08.22278490 — Posted: 2022-08-09
A study to assess the impact of cobas Liat point-of-care PCR assays (SARS-CoV-2 and Influenza A/B) on patient clinical management in the emergency department of the University of California at Davis Medical Center
May, L., Robbins, E., Canchola, J. A., Chugh, K., Tran, N. K.
10.1101/2022.08.08.22278536 — Posted: 2022-08-09
Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave
Tan, S. T., Kwan, A. T., Rodriguez-Barraquer, I., Singer, B. J., Park, H. J., Lewnard, J. A., Sears, D., Lo, N. C.
10.1101/2022.08.08.22278547 — Posted: 2022-08-09
COVID-19 pandemic responses may impact the spread of antibiotic-resistant bacteria: a modelling study
Kovacevic, A., Smith, D. R. M., Rahbe, E., Novelli, S., Henriot, P., Temime, L., Opatowski, L.
10.1101/2022.08.08.503267 — Posted: 2022-08-09
Acetylsalicylic acid and Salicylic acid inhibit SARS-CoV-2 replication in precision-cut lung slices
Geiger, N., König, E.-M., Oberwinkler, H., Roll, V., Diesendorf, V., Faehr, S., Obernolte, H., Sewald, K., Wronski, S., Steinke, M., Bodem, J.
10.1101/2022.08.09.503270 — Posted: 2022-08-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).